BBVA USA Bancshares’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-297
Closed -$43K 667
2019
Q4
$43K Buy
+297
New +$41K ﹤0.01% 550
2016
Q2
Sell
-4,007
Closed -$415K 551
2016
Q1
$415K Sell
4,007
-13,202
-77% -$1.28M 0.03% 378
2015
Q4
$1.71M Sell
17,209
-6,511
-27% -$637K 0.13% 161
2015
Q3
$2.16M Buy
23,720
+187
+0.8% +$18.7K 0.17% 125
2015
Q2
$2.5M Buy
23,533
+1,379
+6% +$153K 0.14% 146
2015
Q1
$2.53M Buy
22,154
+2,366
+12% +$270K 0.11% 177
2014
Q4
$2.18M Buy
19,788
+3,317
+20% +$350K 0.1% 188
2014
Q3
$1.61M Buy
+16,471
New +$1.62M 0.07% 209

Other funds holding ZBH

BBVA USA Bancshares's ZBH Position: Q1 2020 in Review

BBVA USA Bancshares sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 297 shares — an estimated $43K sold.

BBVA USA Bancshares first reported a position in ZBH in Q3 2014 and held it in 8 quarters. The position peaked at $2.53M in Q1 2015. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • BBVA USA Bancshares reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • BBVA USA Bancshares sold 297 Zimmer Biomet shares in Q1 2020, an estimated $43K.
  • BBVA USA Bancshares first reported a position in Zimmer Biomet in Q3 2014 and held it in 8 quarters.
  • BBVA USA Bancshares's Zimmer Biomet position peaked at $2.53M in Q1 2015.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on BBVA USA Bancshares's 13F filing for Q1 2020, filed 27 Apr 2020.